Methods and reagents for treating or preventing atherosclerosis and diseases associated therewith
OwnerChalom B. Sayadainventor
Life of this patent
Estimating the term…
Abstract
The invention features a method for treating, preventing, or reducing the development of an atherosclerosis-associated disease in a patient by administering to the patient a rifamycin in an amount effective to treat, prevent, or prevent the development of the atherosclerosis-associated disease in the patient.
Claims21
A method of treating, preventing, or reducing the development of an atherosclerosis-associated disease in a patient in need thereof, said method comprising administering to said patient a rifamycin in an amount effective to treat, prevent, or reduce the development of said atherosclerosis-associated disease in said patient.
A method of reducing the level of C-reactive protein in a patient identified as having increased levels of C-reactive protein, said method comprising administering to said patient a rifamycin in an amount sufficient to reduce the level of C-reactive protein.
A method for reducing Chlamydia pneumoniae replication in macrophages or foam cells in a patient in need thereof, said method comprising administering a rifamycin to said patient in an amount effective to reduce Chlamydia pneumoniae replication in macrophages or foam cells in said patient.
A method for treating a persistent Chlamydia pneumoniae infection in macrophages or foam cells in a patient, said method comprising administering a rifamycin to said patient in an amount effective to treat said Chlamydia pneumoniae infection in macrophages or foam cells in said patient.
Dependencies are inferred from the claim text.